{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:14:54Z","timestamp":1783329294193,"version":"3.54.6"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","award":["GL261"],"award-info":[{"award-number":["GL261"]}],"id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"US Office of Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["U01-ES032673"],"award-info":[{"award-number":["U01-ES032673"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015136","name":"University of California San Francisco Helen Diller Family Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P50-CA097257"],"award-info":[{"award-number":["P50-CA097257"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K01-DK107607"],"award-info":[{"award-number":["K01-DK107607"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014576","name":"University of California Office of the President","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0348"],"award-info":[{"award-number":["W81XWH-19-1-0348"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201183","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T21:12:09Z","timestamp":1774041129000},"page":"201183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["AAV immuno-gene therapy platform delivering vectorized cytokines defines a new modality for high-grade glioma treatment"],"prefix":"10.1016","volume":"34","author":[{"given":"Akela","family":"Kuwahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan M.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miko","family":"Fogarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangham","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syuan-Ming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy H.","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Rossenberg-Hasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5557-6280","authenticated-orcid":false,"given":"Nicole K.","family":"Paulk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201183_bib1","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015\u20132019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2026.201183_bib2","doi-asserted-by":"crossref","first-page":"71249","DOI":"10.18632\/oncotarget.19531","article-title":"Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy","volume":"8","author":"Medrano","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2026.201183_bib3","first-page":"5155","article-title":"Inhibition of Angiogenesis by Interferons: Effects on Tumor- and Lymphocyte-induced Vascular Responses","volume":"47","author":"Sidky","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201183_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12943-023-01899-4","article-title":"Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omton.2026.201183_bib5","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood.V98.7.2183","article-title":"Apo2L\/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma","volume":"98","author":"Chen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201183_bib6","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41467-021-22033-2","article-title":"Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway","volume":"12","author":"Alicea-Torres","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201183_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fimmu.2013.00483","article-title":"Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response","volume":"4","author":"Schiavoni","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201183_bib8","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20112738","article-title":"Cancer immunoediting by the innate immune system in the absence of adaptive immunity","volume":"209","author":"O\u2019Sullivan","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2026.201183_bib9","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2026.201183_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.149.3685.754","article-title":"Adenovirus-Associated Defective Virus Particles","volume":"149","author":"Atchison","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.omton.2026.201183_bib11","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1128\/JVI.72.11.8568-8577.1998","article-title":"Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue","volume":"72","author":"Duan","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2026.201183_bib12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/mt.2014.22","article-title":"A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses","volume":"22","author":"Markert","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201183_bib13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ymthe.2004.07.021","article-title":"A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting","volume":"10","author":"Chiocca","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201183_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.mt.6300403","article-title":"A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas","volume":"16","author":"Forsyth","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201183_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymthe.2005.08.016","article-title":"Phase I\/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme","volume":"13","author":"Freeman","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201183_bib16","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.ymthe.2017.08.016","article-title":"Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I\/IIa Glioblastoma Trial","volume":"25","author":"Geletneky","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201183_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJMoa1716435","article-title":"Recurrent Glioblastoma Treated with Recombinant Poliovirus","volume":"379","author":"Desjardins","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201183_bib18","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","article-title":"Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo","volume":"75","author":"Nakai","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2026.201183_bib19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","article-title":"Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality","volume":"101","author":"Hudry","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.omton.2026.201183_bib20","first-page":"R292","article-title":"High-flow microinfusion: tissue penetration and pharmacodynamics","volume":"266","author":"Morrison","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.omton.2026.201183_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-006-9308-9","article-title":"Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review","volume":"83","author":"Vogelbaum","year":"2007","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.omton.2026.201183_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.stem.2019.11.015","article-title":"Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma","volume":"26","author":"Bhaduri","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omton.2026.201183_bib23","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.celrep.2018.03.105","article-title":"Glioblastoma Model Using Human Cerebral Organoids","volume":"23","author":"Ogawa","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2026.201183_bib24","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","article-title":"A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo","volume":"76","author":"Hubert","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201183_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1203929","article-title":"Harnessing type I interferon-mediated immunity to target malignant brain tumors","volume":"14","author":"Lim","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201183_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archneur.1983.04050100023008","article-title":"Intrathecal Interferon as Treatment of Multiple Sclerosis: A Planned Multicenter Study","volume":"40","author":"Jacobs","year":"1983","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.omton.2026.201183_bib27","first-page":"321","article-title":"Review of the clinical evidence for interferon \u03b2 1a (Rebif\u00ae) in the treatment of multiple sclerosis","volume":"4","author":"Manfredonia","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.omton.2026.201183_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1215\/S1152851704000821","article-title":"Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme","volume":"7","author":"Giannini","year":"2005","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2026.201183_bib29","unstructured":"JAX. 002019 - Athymic Nude Strain Details. https:\/\/www.jax.org\/strain\/002019."},{"key":"10.1016\/j.omton.2026.201183_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00262-010-0946-6","article-title":"Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model","volume":"60","author":"Maes","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.omton.2026.201183_bib31","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of Mice and Not Men: Differences between Mouse and Human Immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201183_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2004086","article-title":"Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses","volume":"15","author":"Shaw","year":"2017","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omton.2026.201183_bib33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-025-02167-5","article-title":"The multilayered transcriptional architecture of glioblastoma ecosystems","volume":"57","author":"Nomura","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omton.2026.201183_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.omton.2026.201183_bib35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201183_bib36","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal bivalent CAR T cells targeting EGFR and IL13R\u03b12 in recurrent glioblastoma: phase 1 trial interim results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201183_bib37","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJMoa2314390","article-title":"Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma","volume":"390","author":"Choi","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201183_bib38","first-page":"299","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omton.2026.201183_bib39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","article-title":"AAV-based in vivo gene therapy for neurological disorders","volume":"22","author":"Ling","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2026.201183_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","article-title":"The clinical landscape for AAV gene therapies","volume":"20","author":"Kuzmin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2026.201183_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuroimage.2008.11.012","article-title":"Real-time MR imaging of adeno-associated viral vector delivery to the primate brain","volume":"47","author":"Fiandaca","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.omton.2026.201183_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/humc.2016.061","article-title":"Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFN\u03b2-NIS","volume":"27","author":"Zhang","year":"2016","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omton.2026.201183_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55269-6","article-title":"Cell-based interferon gene therapy using proliferation-controllable, interferon-releasing mesenchymal stem cells","volume":"9","author":"Tsujimura","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201183_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1878-0261.12020","article-title":"Intracranial AAV-IFN-\u03b2 gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model","volume":"11","author":"GuhaSarkar","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2026.201183_bib45","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/1479-5876-10-256","article-title":"Adenovirus-mediated delivery of interferon-\u03b3 gene inhibits the growth of nasopharyngeal carcinoma","volume":"10","author":"Liu","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.omton.2026.201183_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1218082","article-title":"Engineering cytokines for cancer immunotherapy: a systematic review","volume":"14","author":"Fu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201183_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2217\/cns-2016-0013","article-title":"Treatment options for recurrent high-grade gliomas","volume":"6","author":"Birk","year":"2017","journal-title":"CNS Oncol."},{"key":"10.1016\/j.omton.2026.201183_bib48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/gt.2017.14","article-title":"MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain","volume":"24","author":"Samaranch","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.omton.2026.201183_bib49","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/ijms25021050","article-title":"Delivery of Adeno-Associated Virus Vectors to the Central Nervous System for Correction of Single Gene Disorders","volume":"25","author":"Daci","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2026.201183_bib50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/pharmaceutics13010040","article-title":"Convection-Enhanced Delivery of a First-in-Class Anti-\u03b21 Integrin Antibody for the Treatment of High-Grade Glioma Utilizing Real-Time Imaging","volume":"13","author":"Nwagwu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omton.2026.201183_bib51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/hgtb.2019.110","article-title":"Fast-Seq: A Simple Method for Rapid and Inexpensive Validation of Packaged Single-Stranded Adeno-Associated Viral Genomes in Academic Settings","volume":"30","author":"Maynard","year":"2019","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omton.2026.201183_bib52","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.stemcr.2017.10.026","article-title":"Systematic Three-Dimensional Coculture Rapidly Recapitulates Interactions between Human Neurons and Astrocytes","volume":"9","author":"Krencik","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omton.2026.201183_bib53","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/hep.23481","article-title":"Adeno-Associated Virus Gene Repair Corrects a Mouse Model of Hereditary Tyrosinemia In Vivo","volume":"51","author":"Paulk","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.omton.2026.201183_bib54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.omtm.2020.05.018","article-title":"Methods Matter: Standard Production Platforms for Recombinant AAV Produce Chemically and Functionally Distinct Vectors","volume":"18","author":"Rumachik","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:18:29Z","timestamp":1783325909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926000597"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201183","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV immuno-gene therapy platform delivering vectorized cytokines defines a new modality for high-grade glioma treatment","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201183"}}